CTVA Stock Recent News

This article explores a market inefficiency in fixed-income securities, specifically between Corteva's $4.50 and $3.50 Series Cumulative Preferred Stocks. We identified an arbitrage opportunity due to technical buying, making it an ideal pair trade with identical issues from the same company. On 02/09/2025, we recommended CTA-B for our investment-grade long-duration portfolio.

INDIANAPOLIS , March 25, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) today announced it will release its first quarter 2025 earnings on Wednesday, May 7, 2025, after the stock market close via press release and its website. The earnings will be presented in a live webcast on Thursday, May 8, 2025, at 9:00 a.m.

Goldman Sachs analyst Duffy Fischer initiated coverage on several major U.S. agriculture input stocks, citing several factors.

Seasoned SaaS and Artificial Intelligence (AI) veteran joins Siteimprove to drive the next phase ofinnovation and growth BELLEVUE, Wash. and COPENHAGEN, Denmark , March 4, 2025 /PRNewswire/ -- Siteimprove, the leading AI-powered SaaS-platform for delivering digital content experiences that are compliant and accessible, today announced that Nayaki Nayyar has been appointed Chief Executive Officer (CEO) and Board Member.

Corteva, Inc. (NYSE:CTVA ) Bank of America Global Agriculture & Materials Conference February 26, 2025 9:00 AM ET Company Participants Chuck Magro – Chief Executive Officer David Johnson – Executive Vice President, Chief Financial Officer Conference Call Participants Steve Byrne – Bank of America Securities Steve Byrne Welcome back. It's a pleasure for me to host this next session with Corteva.

INDIANAPOLIS , Feb. 19, 2025 /PRNewswire/ -- Corteva, Inc. (NYSE: CTVA) announces that Chief Executive Officer, Chuck Magro, and Executive Vice President and Chief Financial Officer, David Johnson, will speak at the 2025 Bank of America Global Agriculture & Materials conference at 9:00 a.m. Eastern Time on Wednesday, February 26, 2025.

This is the first tranche of a Series A Round for IBI Ag's novel bioinsecticide platform. NES TZIONA, Israel , Feb. 13, 2025 /PRNewswire/ -- IBI Ag, a pioneering crop protection company developing a wide array of bio-insecticides with a lower ecological footprint, today announced it has successfully closed the first part of its Series A funding round with a $6.1 million investment.

CTA-B offers a 6.32% current yield, making it an attractive investment-grade preferred stock with solid financial backing from Corteva, Inc. Corteva, Inc.'s strong financial health and low leverage ensure the safety of uninterrupted dividend distributions for CTA-B shareholders. Comparative analysis shows CTA-B is undervalued, offering a potential 10% capital appreciation relative to its peers and Corteva's OTC bonds.

Corteva, Inc. CTVA reported mixed fourth-quarter results, after the closing bell on Wednesday.

Corteva, Inc. (NYSE:CTVA ) Q4 2024 Earnings Conference Call February 6, 2024 9:00 AM ET Company Participants Kim Booth - VP, IR Chuck Magro - CEO David Johnson - EVP and CFO Judd O'Connor - EVP, Seed Business Unit Robert King - EVP, Crop Protection Unit Conference Call Participants Christopher Parkinson - Wolfe Research Vincent Andrews - Morgan Stanley Joel Jackson - BMO Capital Markets Kevin McCarthy - Vertical Research Josh Spector - UBS David Begleiter - Deutsche Bank Salvator Tiano - Bank of America Edlain Rodriguez - Mizuho Frank Mitsch - Fermium Research Richard Garchitorena - Wells Fargo Kristen Owen - Oppenheimer Arun Viswanathan - RBC Capital Markets Ben Theurer - Barclays Bank Operator Thank you for standing by. My name is Janine and I will be your lead operator for today's call.